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ABSTRACT
Objective: To elicit women’s preferences for attributes of alternative man-
agement options for ﬁrst-trimester miscarriage.
Methods: A stated preference discrete-choice experiment was conducted
among 1198 women with a conﬁrmed pregnancy of less than 13 weeks
gestation, who had been diagnosed with either an incomplete miscarriage
or missed miscarriage/early fetal demise and who had been recruited as
part of a randomized controlled trial (miscarriage treatment [MIST] trial)
comparing expectant, medical, and surgical miscarriage. Six attributes,
each with three or four levels, were used in the statistical design. An
orthogonal main effects design was generated (i.e., a design where the
attributes are independent of each other) and the choice sets devised
according to the principles of minimum overlap and level balance. A cost
attribute was included to allow estimation of willingness to pay (WTP)
values. Three different questionnaires were designed such that women
were asked their preferences for attributes of the two management options
they had not been allocated to in the trial.
Results: A total of 630 women completed the stated preference discrete-
choice survey questionnaires: 189 out of 398 women (47.5%) allocated
to expectant management, 223 out of 398 women (56.0%) allocated to
medical management, and 218 out of 402 women (54.2%) allocated to
surgical management. For each of the three discrete-choice survey ques-
tionnaires, women expressed a clear preference for decreased levels of all
six attributes (time spent at the hospital receiving treatment, level of pain
experienced, number of days of bleeding after treatment, time taken to
return to normal activities after treatment, cost of treatment to women,
and chance of complications requiring more time or readmission to hos-
pital). For each of the three discrete-choice survey questionnaires, the
highest valued attribute in terms of WTP was for a reduction in pain levels
followed by time taken to return to normal activities after treatment. On
aggregate, surgical management was valued more highly than expectant
and medical management by women allocated to medical and expectant
management, respectively, and medical management was valued more
highly than expectant management by women allocated to surgical man-
agement. This held true regardless of the application of either hypothetical
data for each attribute generated by the pretrial-designed discrete-choice
experiment questionnaires or actual data for each attribute observed in the
MIST trial.
Conclusions: The preference results generated by this study suggest that
many women undergoing management of ﬁrst-trimester miscarriage
would value being offered alternatives to expectant management. The data
from this study should be considered by decision-makers in conjunction
with the clinical and cost-effectiveness evidence base in this area as well as
consideration of the budgets available to them for such services.
Keywords: discrete-choice experiment, miscarriage, willingness to pay,
women’s preferences.
Introduction
Approximately one in nine conﬁrmed early pregnancies end in
miscarriage during the ﬁrst trimester [1]. The optimal strategy for
managing ﬁrst-trimester miscarriage remains uncertain [2,3]. The
traditional approach of surgical evacuation developed during the
ﬁrst half of the 20th century as a result of high rates of gyneco-
logical infection from the retained products of conception and
the ensuing mortality from septicemia [4]. Nevertheless, surgical
management has been associated with a number of further com-
plications, including uterine perforation, cervical laceration and
infection as a result of instrumentation of the uterus [5]. Two
alternative options to surgical management, expectant manage-
ment and medical management, have increasingly been offered to
women with a diagnosed ﬁrst-trimester miscarriage. Expectant
management allows spontaneous passage of the retained prod-
ucts of conception, while medical management has translated the
treatment regimens widely used for medical terminations of preg-
nancy to the management of spontaneous miscarriage [4].
Randomized controlled trials that have compared alternative
management options for ﬁrst-trimestermiscarriage do not provide
clear evidence of superiority for any onemethod. Three trials have
compared expectant management with surgical management
[6–8], ﬁve trials have compared medical management with surgi-
cal management [9–13], and one trial has compared expectant
management with medical management [14]. Only two trials to
date have directly compared all three management options. The
ﬁrst was curtailed after only 40 women were randomized as a
result of recruitment difﬁculties [15]. The second, the miscarriage
treatment (MIST) trial, the largest trial of management of ﬁrst-
trimester miscarriage to date, found no evidence of a difference in
gynecological infection rates by management option [16]. Never-
theless, signiﬁcantly more unplanned admissions and unplanned
surgical curettage occurred after expectant management and
medical management than after surgical management. The
authors of the study concluded that a similarly sized trial in this
area seems unlikely to be repeated because of a tendency on the
part of women to express a deﬁnite preference for one manage-
ment method and therefore decline randomization [16].
In the absence of clear evidence of clinical superiority from
randomized controlled trials, the decision about which manage-
ment option to offer women with a diagnosed ﬁrst-trimester
miscarriage should be informed by evidence on cost-effectiveness
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and women’s preferences. Indeed, the importance of synthesiz-
ing the valuable aspects of evidence-based, cost-effective, and
preference-driven medicine is being increasingly recognized by
decision-makers in many jurisdictions [17]. Only one of the
randomized controlled trials of the alternative management
options, the MIST trial, conducted a prospective assessment of
cost-effectiveness. The economic evaluation revealed that expect-
ant and medical management of ﬁrst-trimester miscarriage
possess economic advantages over traditional surgical manage-
ment [18]. The net societal cost per woman was estimated at
£1086 in the expectant group, £1410 in the medical group, and
£1585 in the surgical group (£ sterling, 2001–2002 prices).
Expectant management was found to have a 97.8% probability
of being the most cost-effective management method at a
decision-maker’s willingness to pay (WTP) threshold of £10,000
for preventing one gynecological infection, while medical man-
agement only had a 2.2% probability of being the most cost-
effective management method with this threshold.
As with evidence on cost-effectiveness, there is a paucity of
evidence on women’s preferences for alternative management
options for ﬁrst-trimester miscarriage. Two studies assessed
women’s preferences for expectant management versus surgical
management [19,20]. Both studies identiﬁed strong treatment
preferences on the part of women, but their experimental designs
precluded cardinal estimation of strength of preference or the
disentanglement of attributes of the process and consequences of
treatment that directly inﬂuenced women’s responses. One study
used stated preference discrete-choice experiment (SPDCE) meth-
odology to elicit women’s preferences for attributes of surgical
and medical management of miscarriage [21]. The study was
based on a randomized controlled trial of surgical versus medical
management conducted in Scotland. The authors estimated the
trade-offs women were willing to make between ﬁve attributes of
treatment (level of pain experienced, time in hospital receiving
treatment, time taken to return to normal household activities,
cost of treatment to women, and complications after treatment),
and indirectly inferred women’s WTP for changes in the levels of
the noncost attributes. A probit model developed by the authors
implied that overall there was a general preference for surgical
over medical management. In this article, we extend this line of
research by presenting the results of a SPDCE of women’s pref-
erences for attributes of all three management options of ﬁrst-
trimester miscarriage: expectant, medical, and surgical. In so
doing, we aim to make a contribution to the limited evidence
base for decision-makers as they consider the relative merits of
alternative management options.
Methods
SPDCE Methodology
SPDCEs, also sometimes referred to in the literature as conjoint
analysis or discrete-choice modeling, originated in mathematical
psychology but have subsequently been adopted and developed
by market researchers, transport economists, environmental
economists, and more recently health economists. In the health
arena, the technique has been used as a means of eliciting indi-
viduals’ and the community’s preferences for interventions,
models of care, or drug regimes [22]. The technique is based on
the premise that any “good,” for example any health care inter-
vention, drug therapy, treatment or model of care, can be
described by its attributes (or characteristics) and that the extent
to which an individual values a “good” depends on the level of
these attributes. The attributes might describe the impact of the
intervention or model of care on health outcomes, but might also
describe nonhealth outcomes or the process by which the inter-
vention or model of care is delivered [23]. As such, the technique
shares many of the features of the stated preference WTP
approach [24] but has the additional feature of being able to
generate marginal rates of substitution (MRS) between the
attributes, that is, the degree to which respondents are willing to
trade one attribute for another. Indeed, if cost is included as one
of the study attributes, then marginal WTP values can be inferred
for changes in the levels of the remaining attributes. There are
ﬁve identiﬁable stages in the design and analysis of SPDCEs: 1)
identifying the attributes to include in the study; 2) assigning
levels to these attributes; 3) designing the orthogonal matrix of
attributes and levels using design theory; 4) eliciting preferences
for these scenarios; and 5) analyzing the responses. Previous
applications of SPDCEs in the perinatal context include Ryan
and Hughes’s [21] study of women’s preferences for surgical
versus medical management of miscarriage, and studies by Rat-
cliffe and Longworth [25] and Hundley et al. [26] on women’s
preferences for alternative models of intrapartum care.
Study Background and Population
Women recruited into theMIST trial formed the study population.
Full details of the design, conduct, and analysis of the MIST trial
are reported elsewhere [16]. In brief, the MIST trial was a prag-
matic randomized controlled trial that evaluated the beneﬁts,
risks, and costs associated with expectant and medical manage-
ment, in comparison with surgical management, of ﬁrst-trimester
miscarriage. A total of 1200 women with a conﬁrmed pregnancy
of less than 13 weeks gestation, who had been diagnosed through
transvaginal scan with either an incomplete miscarriage (expul-
sion of products of conception has begun) or missed miscarriage/
early fetal demise (visible fetus but absent heart activity), were
recruited from one of seven early pregnancy assessment units in
southern England. Women who consented to participate in the
trial were randomized by telephone to expectant, medical, or
surgical management. Minimization was used to ensure compa-
rability between women allocated to the three management
groups with respect to four prognostic variables: participating
center, parity (nulliparous or parous), miscarriage type (incom-
plete miscarriage or missed miscarriage/early fetal demise), and
gestation (<56 days, 56–76 days, 77 or more days, or unknown).
Women allocated to the expectant group were allowed home with
no intervention. The management of women allocated to the
medical group depended on the type of miscarriage. Those with
incomplete miscarriages were admitted to hospital and given a
single vaginal dose of 800 mg misoprostol (Cytotec, G.D. Serle &
Co., Chicago, IL), while those with missed miscarriages were
pretreated with a single oral dose of 200 mg mifepristone
(Mifeprex, Danco Laboratories, New York, NY) and then admit-
ted 24 to 48 hours later for a single vaginal dose of 800 mg
misoprostol. Women allocated to surgical management were
admitted for surgical evacuation of the retained products of
conception in line with the usual policy of each participating
center. Documented gynecological infectionwithin 14 days of trial
entry constituted the primary clinical outcome of the MIST trial.
This was deﬁned as two ormore of the following: purulent vaginal
discharge; pyrexia >38.0°C; tenderness over the uterus on
abdominal examination; and/or increase in white cell count above
15 ¥ 109/ml. The trial was also designed to include a prospective
economic evaluation that took the form of an incremental cost-
effectiveness analysis [18].
Research Instruments
All women participating in the MIST trial were sent a SPDCE
postal questionnaire 3 months after their miscarriage. A stamped
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addressed envelope was enclosed in the postal pack, and if the
questionnaire had not been returned within 1 month of postage,
then a reminder was sent. Ethical approval for the SPDCE was
received from the South West Multi-Centre Research Ethics
Committee in England.
Three different questionnaires were designed such that
women in each arm of the trial were asked their preferences for
the two management options they had not been allocated to. For
example, women allocated to the surgical management arm
received a SPDCE questionnaire that elicited their preferences for
medical versus expectant management. The purpose of this
approach was to control for the effect of women expressing a
preference for the management option they had been allocated to
[27]. Furthermore, such an approach is in line with cost-beneﬁt
analysis (CBA) theorists who recommend that WTP values that
are to be used within a CBA framework should ideally be elicited
ex ante (i.e., the value of a health change in the case of uncer-
tainty) [28]. Hence, questionnaires 1 (surgical vs. medical), 2
(surgical vs. expectant), and 3 (medical vs. expectant) were
administered to women who had been allocated to expectant,
medical, and surgical management, respectively. In summary, the
survey instrument offered the women a choice between two
management options, neither of which they had been allocated to
as part of the MIST trial.
The attributes and levels included in the experiment were
informed by a literature review and evidence synthesis of previ-
ous research on the approaches to managing ﬁrst-trimester mis-
carriage and their consequences. The attributes (levels) were time
spent at the hospital receiving treatment (overnight, half a day, 1
day), level of pain experienced (low, moderate, severe), number
of days of bleeding after treatment (3 days, 8 days, 14 days), time
taken to return to normal activities after treatment (1–2 days,
3–4 days, 7 days, or more), cost of treatment to women (£50,
£150, £250), and chance of complications requiring more time or
readmission to hospital (very unlikely [about 5 in 100], quite
unlikely [about 10 in 100], unlikely [about 20 in 100]). Women
were informed that, although cost was one of the attributes, the
government has no intention of charging for the treatment of
miscarriage; rather, cost had been included as one way of gauging
how strongly patients valued the different methods of care.
The six attributes and their levels, indicated in Table 1, gen-
erated a total of 972 (35 ¥ 41) possible scenarios. A fractional
factorial design was used to reduce this to a total of 26 scenarios
for each questionnaire. Each type of questionnaire had a constant
comparator for one of the labeled alternative-speciﬁc options
(surgical management for questionnaires 1 and 2 and medical
management for questionnaire 3). The constant comparator sce-
nario attributes and levels were devised from the SPDCE
attributes and levels and modeled as closely as possible to sce-
narios representing surgical, medical, and expectant management
based on evidence from the literature and expert advice at the
outset of the trial (see Table 2). This design gave rise to a total of
25 choice sets for each questionnaire. Twenty-ﬁve choice sets
were considered to be too burdensome for women; consequently,
each questionnaire was blocked into two questionnaires (1a, 1b,
2a, 2b, 3a, and 3b), with either 12 or 13 choice sets. For the
purposes of analysis and to treat the questionnaires statistically
appropriately as a complete block, however, individual “a” and
“b” blocks for each of questionnaires 1, 2, and 3 were combined
and analyzed as one questionnaire. The alternative scenarios
were generated through an orthogonal design using SPEED sta-
tistical software (version 2.1, Hague Consulting Group, Hague,
The Netherlands) and set against the chosen constant compara-
tor in the resulting choice sets. This was a somewhat unusual
design because it was not perfectly orthogonal. Nevertheless, our
experimental design did satisfy the main criteria at the time for
efﬁcient DCE design: near orthogonal-in-differences, minimum
overlap, level balance, plausible, and realistic (Zwerina et al.
1996, unpublished). It should be noted that the most recent
design literature recommends using more statistically sound fold-
over designs. Moreover, the criteria for efﬁcient SPDCE designs
have been developed in recent years and, as such, additional
criteria such as zero correlation and maximizing D-optimality are
now employed [29]. For each choice set, women were asked
which option they preferred. An example choice set is shown in
Figure 1.
Data Analysis
The sociodemographic and health status characteristics of women
who did and did not return a completed DCE questionnaire were
compared using the Student’s t test for continuous variables and
the chi-square test for categorical variables. The discrete-choice
responses were analyzed using a random effects probit model
available in LIMDEP. In this model, there is an overall intercept
and an error term with two components: eit and mi. The eit is the
traditional error term unique to each observation, and the mi is an
error term representing the extent to which the intercept of the ith
unit differs from the overall intercept [30]. This type of model
essentially accounts for the repeated nature of the data (i.e., the
multiple choices per individual). Because the design of the SPDCE
was a labeled experiment, otherwise known as an “alternative
Table 1 Attributes and levels used in the stated preference discrete-
choice experiment design
Attribute Levels
Time spent at the hospital receiving
treatment
Overnight
Half a day
1 day
Level of pain experienced Low
Moderate
Severe
Number of days of bleeding after treatment 3 days
8 days
14 days
Time taken to return to normal
activities after treatment
1–2 days
3–4 days
5–6 days
7 days or more
Cost of treatment to women £50
£150
£250
Chance of complications requiring
more time or readmission to
hospital
Very unlikely (about 5 in 100)
Quite unlikely (about 10 in 100)
Unlikely (about 20 in 100)
Table 2 Pretrial scenarios for surgical, medical, and expectant manage-
ment of miscarriage based on trial attributes and levels
Attributes
Surgical
scenario
Medical
scenario
Expectant
scenario
Time spent at hospital receiving
treatment
1 day 0.5 day 0.5 day
Level of pain experienced Low Moderate Moderate
Number of days bleeding after
treatment
3 days 8 days 14 days
Time taken to return to normal
activities after treatment
3–4 days 3–4 days 3–4 days
Chance of complications
requiring more time or
readmission to hospital
5% 10% 5%
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speciﬁc” discrete-choice experiment as opposed to a “generic” or
unlabeled design, a constant term was also included to allow for
testing of inherent preferences for the labeled, i.e., alternative
speciﬁc, options when assuming that the attributes and levels are
equivalent. Such a design allows the “label” or name of the option
to convey information to the decision-maker beyond the included
attributes and levels. Such a design matters in some choice experi-
ments because 1) subjects may use labels to infer missing (omitted)
information; and 2) these inferences may be correlated with the
random component of the error term. Incorporating alternative-
speciﬁc constant terms in such a labeled design allows testing for
the effect of preferences on attributes beyond those included in the
design and interpreted by the respondent as inherent in the choice
“label.”
WTP values were obtained by estimating the MRS between
the noncost attribute coefﬁcients and the cost coefﬁcient. Conﬁ-
dence intervals (CI) around the WTP values were obtained using
the variance–covariance matrix of the noncost attribute coefﬁ-
cients and the cost coefﬁcient [31]. The theoretical validity of the
valuations was assessed by determining whether the estimated
parameters for each coefﬁcient were of the appropriate algebraic
sign, i.e., whether increased levels of time spent in hospital receiv-
ing treatment, pain, number of days of bleeding after treatment,
time taken to return to normal activities after treatment, cost to
women, and chance of complications decreased utility (led to a
negative coefﬁcient). The internal consistency of a woman’s
responses was investigated by including between two and four
choice sets within each questionnaire in which one option was
superior to the other across some attributes and no worse than
the other across any remaining attributes. Finally, overall synthe-
sized monetary estimates of welfare shifts between management
options were derived using both hypothetical data for each
attribute generated by the pretrial-designed SPDCE question-
naires, as well as actual trial data for each attribute observed in
the MIST trial. Differences between the WTP values were con-
sidered statistically signiﬁcant if the 95% CI generated were not
overlapping.
Results
A total of 1200 women participated in the MIST trial, two of
whom were subsequently found to have a viable pregnancy. The
clinical and sociodemographic characteristics at trial entry of the
remaining 1198 women are presented in Table 3. Of these 1198
women, 648 returned the SPDCE questionnaires, a response rate
of 54.1% that reﬂects positively in comparison with other
Scenario 2 
Surgical
Treatment 
Expectant
Treatment 
Time spent at the hospital receiving treatment 1 day ½ day 
 etaredoM woL decneirepxe niap fo leveL
Number of days of bleeding following treatment 3 days 8 days 
Time taken to return to normal activities after 
treatment 3-4 days 5-6 days 
Cost to you of treatment (if you were paying) £150 £50 
Chance of complications requiring more time or 
readmission to hospital 
Very unlikely 
(about 5 in 100) 
Quite unlikely 
(about 10 in 100) 
Prefer Surgical Prefer Expectant
For scenario 2, which treatment would you prefer?
Figure 1 An example choice set included in
discrete-choice experiment.
Table 3 Clinical and sociodemographic characteristics at trial entry of women who participated in the MIST trial
Characteristic
Expectant Medical Surgical
398 (%) 398 (%) 402 (%)
Age
Mean [SD] 31.3 [5.8] 31.2 [5.9] 31.5 [5.8]
Gestational age (days)
<56 26 (7) 18 (5) 25 (6)
56–76 168 (42) 168 (42) 173 (43)
77 or more 147 (37) 155 (39) 147 (37)
Not known 57 (14) 57 (14) 57 (14)
Parity
Nulliparous 170 (43) 172 (43) 175 (44)
Parous 228 (57) 226 (57) 227 (56)
Type of miscarriage
Missed 306 (77) 308 (78) 310 (77)
Incomplete 92 (23) 90 (23) 92 (23)
Bleeding at entry 340 (85) 331 (83) 335 (83)
Pain at entry 213 (54) 206 (52) 205 (51)
Ultrasound ﬁndings
AP diameter
Mean [SD] 23.2 [11.6] 23.5 [13.0] 22.4 [11.6]
Median {IQR} 21.0 {14–30} 21.0 {14–30} 21.0 {14–29}
In employment 292 (73.4) 301 (75.6) 280 (69.7)
MIST, miscarriage treatment; SD, standard deviation;AP, anterior posterior; IQR, interquartile range.
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SPDCE postal surveys [22,23]. There were no signiﬁcant differ-
ences between women who did and did not return the question-
naire in terms of their age, gestational age at miscarriage, parity,
type of miscarriage, and management method of allocation,
although nonresponders were less likely to be in paid employ-
ment. Of the 398 women allocated to expectant management,
198 (49.6%) returned the DCE questionnaire. The response rates
were 228 out of 398 (57.3%) and 222 out of 402 (55.1%)
among women allocated to medical and surgical management,
respectively. There were no signiﬁcant differences in terms of
clinical and sociodemographic characteristics between women
allocated to the three management methods who returned the
SPDCE questionnaire. After the removal of missing values (entire
respondents were only removed where all variables were
missing), analyzable responses were available for 189 women
(47.5%) (2331 observations) allocated to expectant manage-
ment, 223 women (56.0%) (2771 observations) allocated to
medical management, and 218 women (54.2%) (2711 observa-
tions) allocated to surgical management. The checks for internal
consistency of responses revealed consistency rates of 77.1%,
84.5%, and 93.1% among women allocated to expectant,
medical, and surgical management, respectively, and an overall
consistency rate of 83.6%. There were no signiﬁcant differences
in terms of clinical and sociodemographic characteristics
between women allocated to the three management methods
who provided consistent responses.
Tables 4–6 present the results from the random effects probit
models for women allocated to expectant, medical, and surgical
management, respectively. The models appear to ﬁt the data well,
with more than 75% of observations correctly predicted. The
statistical signiﬁcance of P < 0.001 in all three models supports
the use of this approach. The estimated coefﬁcients for the
attributes included in the SPDCE design are all of the theoreti-
cally anticipated sign and are all statistically signiﬁcant. Women
Table 4 Random effects probit, baseline model for women allocated to expectant management
Variable Attribute unit Coefﬁcient SE P-value
WTP (£) per unit
decrement (95% CI)
Constant — 0.299 0.1692 0.08 —
Time spent at hospital receiving treatment Days -0.0436 0.0056 <0.001 £13.74 (£13.66, £13.81)
Number of days of bleeding after treatment Days -0.0549 0.0103 <0.001 £17.30 (£17.12, £17.48)
Time taken to return to normal activities after treatment Days -0.166 0.0210 <0.001 £52.25 (£51.15, £53.35)
Cost to woman of treatment £ -0.00318 0.0006 <0.001 —
Chance of complications requiring more time or readmission
to hospital
% -0.0586 0.0092 <0.001 £18.46 (£18.29, £18.63)
Level of pain experienced (ref = low)
Moderate Category -0.581 0.1215 <0.001 £182.89 (£160.67, £205.11)
Severe Category -1.743 0.1272 <0.001 £548.51 (£478.75, £618.26)
Number of observations: 2331
Unbalanced panel: 189 individuals
Log-likelihood function: -703.09
Restricted log-likelihood: -1217.7
Chi-square: 186.7
Signiﬁcance level: <0.001
Hosmer-Lemeshow chi-square: 6.22
% Correct predictions: 76%
Choice probabilities: Surgery: 75%; Medical: 25%
SE, standard error;WTP, willingness to pay; CI, conﬁdence interval.
Table 5 Random effects probit, baseline model for women allocated to medical management
Variable Attribute unit Coefﬁcient SE P-value
WTP (£) per unit
decrement (95% CI)
Constant — 0.198 0.154 0.199 —
Time spent at hospital receiving treatment Days -0.037 0.0059 <0.001 £14.64 (£14.56, £14.73)
Number of days of bleeding after treatment Days -0.071 0.0094 <0.001 £27.61 (£27.35, £27.87)
Time taken to return to normal activities after treatment Days -0.186 0.0214 <0.001 £72.34 (£70.79, £73.89)
Cost to woman of treatment £ -0.0025 0.0005 <0.001 —
Chance of complications requiring more time or readmission to
hospital
% -0.0291 0.0084 <0.001 £11.34 (£11.24, £11.43)
Level of pain experienced (ref = low)
Moderate Category -0.486 0.114 <0.001 £189.39 (£167.80, £210.99)
Severe Category -1.963 0.106 0.001 £763.40 (£682.25, £844.55)
Number of observations: 2771
Unbalanced panel: 223 individuals
Log-likelihood function: -824.15
Restricted log-likelihood: -1446.6
Chi-square: 256.32
Signiﬁcance level: <0.001
Hosmer-Lemeshow chi-square: 2.97
% Correct predictions: 75%
Choice probabilities: Surgery: 74.4%; Expectant: 25.6%
SE, standard error;WTP, willingness to pay; CI, conﬁdence interval.
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in all three arms of the trial, therefore, expressed a clear prefer-
ence for decreased levels of time spent in hospital receiving
treatment, pain, number of days of bleeding after treatment, time
taken to return to normal activities after treatment, personal
cost, and chance of complications. These results support the
theoretical validity of the study design. The effects are broadly
similar across the three management methods of allocation. In
none of the random effects probit models was the alternative-
speciﬁc constant term a signiﬁcant predictor of choice at the 5%
signiﬁcance level. This latter result implies that women’s prefer-
ences were a function of the attributes and levels provided and
not driven by underlying preferences for attributes excluded from
the study.
Table 7 shows estimates of women’s WTP for unit decreases
in the noncost attributes segmented by each management method
of allocation. The WTP estimates are derived by taking the ratio
of the estimated coefﬁcient for each noncost attribute to that of
the cost coefﬁcient [22]. These results help to assess the relative
valuation of different attributes depending upon which arm of
the trial the respondents were allocated to and, by implication,
the management options being offered for preference elicitation
in the SPDCE. The highest WTP estimate is for a reduction in the
pain experienced, estimated at £182.89 (95% CI: £160.67,
£205.11), £189.39 (95% CI: £167.80, £210.99), and £196.89
(95% CI: £177.69, £216.09) for a reduction from moderate to
low pain among women allocated to expectant, medical, and
surgical management, respectively, and at £548.51 (95% CI:
£478.75, £618.26), £763.40 (95% CI: £682.25, £844.55), and
£793.50 (95% CI: £707.94, £879.06) for a reduction from
severe to low pain among women allocated to expectant,
medical, and surgical management, respectively. The second most
important attribute, as imputed by women’s WTP, is time taken
to return to normal activities after treatment, followed by
number of days of bleeding after treatment, chance of complica-
tions requiring more time or readmission to hospital, and time
spent at hospital receiving treatment. The WTP values for unit
changes in the synthesized WTP analysis shown in Table 7 dif-
fered signiﬁcantly between women allocated to the three man-
agement methods. The WTP values were highest among women
allocated to surgical management for the attributes related to the
number of days of bleeding, time taken to return to normal
activities, chance of complications and level of pain, and highest
among women allocated to medical management for the “time
spent at hospital” attribute.
Finally, synthesizing the marginal WTP values summarized in
Table 7 with the descriptions of the management options in the
pretrial-designed SPDCE scenarios generated overall monetary
estimates of welfare shifts between alternative sets of attributes
Table 6 Random effects probit, baseline model for women allocated to surgical management
Variable Attribute unit Coefﬁcient SE P-value
WTP (£) per unit
decrement (95% CI)
Constant — 0.0021 0.1228 0.98 —
Time spent at hospital receiving treatment Days -0.033 0.0047 <0.001 £14.02 (£13.95, £14.08)
Number of days of bleeding after treatment Days -0.0957 0.0089 <0.001 £40.62 (£40.26, £40.99)
Time taken to return to normal activities after treatment Days -0.211 0.0179 <0.001 £89.74 (£88.13, £91.34)
Cost to woman of treatment £ -0.0023 0.0004 <0.001 —
Chance of complications requiring more time or readmission
to hospital
% -0.062 0.0073 <0.001 £26.52 (£26.32, £26.71)
Level of pain experienced (ref = low)
Moderate Category -0.463 0.0975 <0.001 £196.89 (£177.69, £216.09)
Severe Category -1.869 0.107 <0.001 £793.50 (£707.94, £879.06)
Number of observations: 2711
Unbalanced panel: 218 individuals
Log-likelihood function: -967.03
Restricted log-likelihood: -1247.86
Chi-square: 524.9
Signiﬁcance level: <0.001
Hosmer-Lemeshow chi-square: 9.44
% Correct predictions: 79%
Choice probabilities: Medical: 75.5%; Expectant: 24.5%
SE, standard error;WTP, willingness to pay; CI, conﬁdence interval.
Table 7 Comparison of WTP values across the three management methods of allocation
Attribute Unit
WTP (£) per unit decrement (95% CI*)
Women allocated to
expectant management
Women allocated to
medical management
Women allocated to
surgical management
Time spent at hospital receiving treatment Days £13.74 (£13.66, £13.81) £14.64 (£14.56, £14.73) £14.02 (£13.95, £14.08)
Number of days of bleeding after treatment Days £17.30 (£17.12, £17.48) £27.61 (£27.35, £27.87) £40.62 (£40.26, £40.99)
Time taken to return to normal activities
after treatment
Days £52.25 (£51.15, £53.35) £72.34 (£70.79, £73.89) £89.74 (£88.13, £91.34)
Chance of complications requiring more
time or readmission to hospital
% £18.46 (£18.29, £18.63) £11.34 (£11.24, £11.43) £26.52 (£26.32, £26.71)
Level of pain experienced (ref = low)
Moderate Category £182.89 (£160.67, £205.11) £189.39 (£167.80, £210.99) £196.89 (£177.69, £216.09)
Severe Category £548.51 (£478.75, £618.26) £763.40 (£682.25, £844.55) £793.50 (£707.94, £879.06)
*Derived from the variance covariance matrix.
WTP, willingness to pay.
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representing management options. These WTP values were cal-
culated by management method of allocation. Hence, they rep-
resent the values of women allocated to each management
method for welfare shifts between the management methods they
were not allocated to. These were estimated at £354.82 (95% CI:
£330.89–£378.76) for a shift from medical to surgical man-
agement (values of women allocated to expectant management),
£485.76 (95% CI: £461.37–£510.20) for a shift from expectant
to surgical management (values of women allocated to medical
management), and £111.15 (95% CI: £109.96–£112.39) for a
shift from expectant to medical management (values of women
allocated to surgical management). The overall monetary esti-
mates of welfare shifts that were calculated using actual mean
MIST trial data for each attribute observed, as shown in Table 8,
were more conservative however at £36.31 (95% CI: £35.94–
£36.71) for a shift from medical to surgical management (values
of women allocated to expectant management), £161.04 (95%
CI: £158.70–£163.40) for a shift from expectant to surgical
management (values of women allocated to medical manage-
ment), and £131.08 (95% CI: £129.16–£133.01) for a shift from
expectant to medical management (values of women allocated to
surgical management).
Discussion and Conclusions
The results presented in this article provide new information
about women’s preferences for attributes of alternative manage-
ment options for ﬁrst-trimester miscarriage. The results suggest
that the level of pain experienced by women is the most impor-
tant determinant of their preferences (as indicated by the highest
WTP per unit decrement). Time taken to return to normal activi-
ties after treatment, number of days of bleeding after treatment,
chance of complications requiring more time or readmission to
hospital, and time spent at hospital receiving treatment are also
statistically signiﬁcant determinants.
The results are broadly in line with evidence from qualitative
studies that highlight the levels of pain and bleeding as critical in
women’s perceptions of their miscarriage experiences [32–34].
Furthermore, the results of this study concur with the only other
SPDCE of women’s preferences for attributes of ﬁrst-trimester
miscarriage, the study by Ryan and Hughes [21], which identiﬁed
a general preference for surgical over medical management. In
the study by Ryan and Hughes [21], “complications following
treatment” was the primary determinant of women’s preferences
followed by “level of pain experienced.” In addition, this study
highlighted that preferences, in terms of WTP values for attribute
shifts, varied signiﬁcantly between women allocated to differing
arms of the trial. This implies that preferences for the attribute
shifts may be a function of the care women actually received. In
the absence of data mining, such a result could possibly be
explained in terms of women’s management experiences inﬂu-
encing their perception of attributes. Nevertheless, it is recom-
mended that future studies incorporate appropriate qualitative
research to explore this result in a more systematic fashion.
The study presented here also imputed monetary beneﬁts of
shifts between management options. On aggregate, surgical man-
agement was valued more highly than expectant and medical
management by women allocated to medical and expectant man-
agement, respectively, while medical management was valued
more highly than expectant management by women allocated to
surgical management. These results were replicated regardless of
the application of either hypothetical data for each attribute
generated by the pretrial-designed DCE questionnaires or actual
data for each attribute observed in the MIST trial. When these
overall monetary estimates are considered in conjunction with
the clinical and cost-effectiveness results from the MIST trial,
however, there appears to be a divergence of results. The cost-
effectiveness analysis based on the MIST trial revealed that
expectant management was in fact the most cost-effective option
[18]. Future research planned by the authors will integrate the
preference data presented in this article with the clinical and
cost-effectiveness data generated by the MIST trial within a
formal CBA framework.
Although the study design adhered to appropriate method-
ological practice on application of DCEs within health care [35]
at the time of conduct and produced results that can be consid-
ered theoretically valid and of relevance to clinicians and
decision-makers, there are a number of caveats that should be
borne in mind by readers. First, there have been a number of
improvements to SPDCE design theory since the design and
inception of this study, and thus further work in this area should
consider these improvements in methodology [36]. In relation to
the estimation of WTP values using SPDCEs, recent work by
Lancsar and Savage has recommended that welfare estimates
must also take account of the probability of choosing a good,
suggesting that the welfare values must be implicitly weighted by
the probability of choosing each alternative in the choice set [37].
Nevertheless, Ryan has also shown that when using state of the
world models (as in this study where the choice is binary), the
formula advocated by Lancsar and Savage reduces to the method
traditionally used by health economists (and used in this analysis)
[38]. Nevertheless, further consideration may need to be given on
how best to reconcile the DCE-generated welfare estimates and
binary choice probabilities. Future studies that offer women all
three management options to choose from and allow for the
probability of choice as recommended by Lancsar [37] may ﬁnd
these impacts the WTP values for the alternative management
options. Second, and also with regard to the design of the DCE,
the alternative options were generated through an orthogonal
design and set against the constant comparator in the resulting
choice sets. Nevertheless, it is now accepted that this is not the
most statistically robust technique and future studies should
model the constant comparator as a function of the attributes
and levels of the main orthogonal, fold-over design. Third, the
analyses presented here are all at the aggregate level. Ongoing
further research will assess whether and how preferences vary
according to the characteristics of respondents, e.g., whether
women with different types of miscarriage, who differed in their
clinical outcomes in the MIST trial [16], have different preference
structures, or whether women from different socioeconomic
groups differ in their WTP values. Fourth, we were unable to
conduct formal pretesting of our research instruments or
follow-up debrieﬁng with respondents about their experience of
completing the DCE questionnaire. Synergistic application of
Table 8 Post-trial scenarios for surgical, medical, and expectant man-
agement of miscarriage based on actual MIST trial data
Attributes
Surgical
scenario
Medical
scenario
Expectant
scenario
Time spent at hospital receiving
treatment
1 day 1.2 days 0 days
Level of pain experienced Low Low Low
Number of days bleeding after treatment 8 days 11 days 12 days
Time taken to return to normal activities
after treatment
6.7 days 6.7 days 12 days
Chance of complications requiring more
time or readmission to hospital
3% 2% 3%
MIST, miscarriage treatment.
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qualitative and quantitative research in our study methods could
have provided insight into the respondents’ understanding of the
experiment, the validity of the choice sets, and their cognitive
processes when selecting between choice sets [39]. Fifth, while
the survey could have beneﬁted from further reminders to
improve the response rate [40], it was felt that because of the
unpleasant nature of the women’s recent health circumstances, it
was important for the survey not to be overly burdensome.
Finally, if this study were to be repeated, it is recommended that
future SPDCEs in this area use the same questionnaire for all
respondents and simply control for their level of experience at the
analysis stage as opposed to controlling for their experience at
the design stage as in our study. Using the same questionnaire
would allow the results to be more comparable across women.
In conclusion, this study provides new evidence of women’s
preferences for attributes of alternative management options for
ﬁrst-trimester miscarriage, as well as overall monetary estimates
of welfare shifts between alternative management options. The
results from this study reveal that many women undergoing
management of ﬁrst-trimester miscarriage would value being
offered alternatives to expectant management as deﬁned by the
attributes in our survey. Data from this study should however be
considered by decision-makers, in conjunction with the clinical
and cost-effectiveness evidence base in this area, as well as con-
sideration of the budgets available to them for such services.
Further research that establishes the validity of our results would
aid decision-makers in their deliberations.
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